Clinical Trial Update: Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating inhaled Technosphere Insulin in subjects with diabetes mellitus (types 1 and 2) and asthma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Technosphere insulin (insulin inhalation)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED